Literature DB >> 17286006

[The effects of tetrandrine on activity of collagenase derived from human hypertrophic scar].

Zhi-dong Cao1, Chong-rong Shi, Chong-ben Huang, Bang-chun Li, Jing-yue Gou, Yuan-lu Liu, Kui Zhang.   

Abstract

OBJECTIVE: To observe the effect of tetrandrine on activity of collagenase derived from human hypertrophic scar for the sake of clarifying the mechanism as tetrandrine acting on scar.
METHODS: The experimental concentration was controlled below that of cell proliferation inhibited, SDS-PAGE electrophoresis was adopted to separate collagenase from extracellular matrix, and then activated by trypsin analyzed the activity of collagenase with density scanning apparatus. At the same time quantity of extracellular collagen was measured using improved chloraseptine T oxidizing assay, moreover analyzed correlation between activity of collagenase and quantity of extracellular collagen.
RESULTS: In the concentration below the lever of inhibiting fibroblast proliferation, the total activity of collagenase could be significantly increased by tetrandrine with dosage-dependence associated with quantity of extracellular collagen reduced, which was much greater than that of triamcinolone.
CONCLUSION: Increasing activity of collagenase on degradation of collagen even in a lower concentration was one of the mechanisms of tetrandrine treating hypertrophic scar.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17286006

Source DB:  PubMed          Journal:  Zhonghua Zheng Xing Wai Ke Za Zhi        ISSN: 1009-4598


  2 in total

Review 1.  Medicinal plants for the treatment of hypertrophic scars.

Authors:  Qi Ye; Su-Juan Wang; Jian-Yu Chen; Khalid Rahman; Hai-Liang Xin; Hong Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-11       Impact factor: 2.629

2.  A novel controlled release tetrandrine-loaded PDLLA film: evaluation of drug release and anti-adhesion effects in vitro and in vivo.

Authors:  Hai Yao; Zhidong Cao; Lei Peng; Jian Liu; Xiaoxing Zhang; Zhilong Deng
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.